Market Overview:
The global addison's disease treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of addison's disease, rising awareness about the condition, and technological advancements in the field of addison's disease treatment. The global addison's disease treatment market is segmented on the basis of type, application, and region. On the basis of type, it is divided into oral corticosteroid and corticosteroid injections. Oral corticosteroids are further classified into synthetic glucocorticoids and mineralocorticoids. Corticosteroid injections are sub-divided into depot preparations and single-injection preparations. On the basis of application, it is segmented into hospitals, clinics, and others (research institutes/laboratories). Geographically speaking, it covers North America (the U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U K Rest Of Europe), Asia Pacific excluding Japan) (China India Australia South Korea Rest Of APAC), Japan) Middle East & Africa(GCC Countries Israel South Africa Rest Of MEA).
Product Definition:
Addison's disease is a disorder of the endocrine system that results in the insufficient production of cortisol and aldosterone by the adrenal glands. Treatment involves taking replacement hormones to supplement what the body is not making.
Oral Corticosteroid:
Oral corticosteroid is a medication that reduces inflammation by decreasing the production of cytokines. Corticosteroids are naturally occurring hormones that regulate functions such as immune response, inflammatory response, and stress responses in the body. Oral corticosteroids can be prescribed to reduce Addison's disease-related symptoms such as excessive sweating, itchy skin or eyes, frequent urination or diarrhea among others.
Corticosteroid Injections:
Corticosteroid Injections are used in Addison's disease treatment. It is also known as adrenal insufficiency or Addison's disease. This rare disorder is caused by a deficiency of a hormone called Corticosteroid and its symptoms include fatigue, weakness, and weight loss due to low levels of cortisol in the body.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The other applications include travel medicine, home healthcare and self-medication among others. Self-medication is the most preferred method for Addison¢â‚¬â„¢s disease treatment as compared to going to a hospital or clinic due to lack of medical insurance or financial assistance and high cost associated with it. Thus, self-treatment is prevalent among patients suffering from Addison¢â‚¬â„¢s disease at home without consulting a doctor which may result in improper management of the condition resulting in higher prevalence rate over a period of time.
Hospital based clinics are preferred by many patients owing to their accessibility.
Regional Analysis:
North America dominated the market in 2017 owing to a rise in awareness about Addison's disease and its treatment, increasing healthcare expenditure, and availability of effective therapies. Moreover, high adoption of new technologies for diagnosis & treatment is also expected to drive the regional market over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to rising disposable income & improving healthcare infrastructure. In addition, increasing prevalence of diseases such as HIV/AIDS and cancer are anticipated to fuel growth in this region. The presence of unmet medical needs coupled with rapidly growing economy offers tremendous opportunities for key players operating in this space which will further boost growth prospects during the forecast years.
Growth Factors:
- Increasing incidence of Addison's disease
- Growing awareness about the symptoms and treatment of Addison's disease
- Rising demand for better and more effective treatments for Addison's disease
- Availability of government funding for research on Addison's disease
- Growing number of clinical trials being conducted on new therapies for Addison's disease
Scope Of The Report
Report Attributes
Report Details
Report Title
Addison's Disease Treatment Market Research Report
By Type
Oral Corticosteroid, Corticosteroid Injections
By Application
Hospitals, Clinics, Others
By Companies
Pfizer, GlaxoSmithKline, Takeda, Abbott Laboratories, Merck, Boehringer Ingelheim, Amgen, Lupin Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Addison's Disease Treatment Market Report Segments:
The global Addison's Disease Treatment market is segmented on the basis of:
Types
Oral Corticosteroid, Corticosteroid Injections
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline
- Takeda
- Abbott Laboratories
- Merck
- Boehringer Ingelheim
- Amgen
- Lupin Pharmaceuticals
Highlights of The Addison's Disease Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Corticosteroid
- Corticosteroid Injections
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Addison's Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no cure for Addison's Disease, but there are treatments that can help manage the symptoms. Treatment options may include medication, surgery, and other therapies.
Some of the major companies in the addison's disease treatment market are Pfizer, GlaxoSmithKline, Takeda, Abbott Laboratories, Merck, Boehringer Ingelheim, Amgen, Lupin Pharmaceuticals.
The addison's disease treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Addison's Disease Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Addison's Disease Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Addison's Disease Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Addison's Disease Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Addison's Disease Treatment Market Size & Forecast, 2018-2028
4.5.1 Addison's Disease Treatment Market Size and Y-o-Y Growth
4.5.2 Addison's Disease Treatment Market Absolute $ Opportunity
Chapter 5 Global Addison's Disease Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Addison's Disease Treatment Market Size Forecast by Type
5.2.1 Oral Corticosteroid
5.2.2 Corticosteroid Injections
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Addison's Disease Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Addison's Disease Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Addison's Disease Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Addison's Disease Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Addison's Disease Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Addison's Disease Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Addison's Disease Treatment Market Size Forecast by Type
9.6.1 Oral Corticosteroid
9.6.2 Corticosteroid Injections
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Addison's Disease Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Addison's Disease Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Addison's Disease Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Addison's Disease Treatment Market Size Forecast by Type
10.6.1 Oral Corticosteroid
10.6.2 Corticosteroid Injections
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Addison's Disease Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Addison's Disease Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Addison's Disease Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Addison's Disease Treatment Market Size Forecast by Type
11.6.1 Oral Corticosteroid
11.6.2 Corticosteroid Injections
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Addison's Disease Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Addison's Disease Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Addison's Disease Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Addison's Disease Treatment Market Size Forecast by Type
12.6.1 Oral Corticosteroid
12.6.2 Corticosteroid Injections
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Addison's Disease Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Addison's Disease Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Addison's Disease Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Addison's Disease Treatment Market Size Forecast by Type
13.6.1 Oral Corticosteroid
13.6.2 Corticosteroid Injections
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Addison's Disease Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Addison's Disease Treatment Market: Competitive Dashboard
14.2 Global Addison's Disease Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GlaxoSmithKline
14.3.3 Takeda
14.3.4 Abbott Laboratories
14.3.5 Merck
14.3.6 Boehringer Ingelheim
14.3.7 Amgen
14.3.8 Lupin Pharmaceuticals
